Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier

This article was originally published in PharmAsia News

Executive Summary

By Zhu Shen, Chief Executive Officer, BioForesight

You may also be interested in...



Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference

SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight

Barack Obama's Meeting With Chinese President Bodes Well For Pan-Pacific Pharma Partnerships, Says Analyst During Shanghai Conference

SHANGHAI - Despite the financial maelstrom that has lashed economies from the Americas to Asia, U.S. President Barack Obama's April 1 meeting with Chinese President Hu Jintao is ultimately likely to boost the pharmaceutical sector in each country and the potential for pan-Pacific partnerships, according to the chief executive officer of the San Diego-based consulting firm BioForesight

Sundia Meditech’s CEO On Driving Innovation In China’s Pharma Sector

China will be world’s second largest pharma market by 2020, CRO chief predicts.

Related Content

UsernamePublicRestriction

Register

SC068866

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel